Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
2.220
-0.060 (-2.63%)
May 8, 2026, 4:00 PM EDT - Market closed
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $11.5 million as of May 8, 2026.
Market Cap
11.50M
Enterprise Value
5.32M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.22
Market Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $11.50M, a decrease of -70.84%. That is a compound annual growth rate of -94.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 11.50M | -67.06% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Milestone Scientific | 40.41M |
| Nephros | 37.47M |
| Harvard Bioscience | 31.10M |
| Femasys | 25.96M |
| Retractable Technologies | 20.86M |
| Jin Medical International | 16.59M |
| Bionano Genomics | 14.31M |
| Lucyd | 6.49M |